Skip to content
Finance Investment, Medical Health Aged Care

Medicinal cannabis company Little Green Pharma (ASX:LGP) records record quarterly revenue and cash receipts

Little Green Pharma 3 mins read
LGP Chief Executive Officer, Paul Longn

RECORD REVENUE AND CASH RECEIPTS FOR QUARTER AND FINANCIAL YEAR,

POSITIVE OPERATING CASHFLOW FOR FY24 OF $0.5 MILLION

 

Highlights 

  • Record quarterly cash receipts of $8.1 million, up over 50% on previous quarter and over 20% on previous corresponding period
  • Record quarterly revenue of $7.3 million (unaudited), up 34% on previous quarter and over36% on previous corresponding period
  • Record revenue of $25.6million (unaudited) for FY24, up nearly 30% on previous financial year resulting in positive operating cashflow of $0.5million for financial year
  • Cannabis legalised in Germany with its removal from the Narcotics List
  • Cash in bank of $5.0 million at 31 March 2024 up from $3.7 million at 31 December 2023

To view a copy of the company's Quarterly Activities Report lease click here

About Little Green Pharma

Little Green Pharma is a global, vertically integrated and geographically diverse medicinal cannabis business with operations from cultivation and production through to manufacturing and distribution.

The Company has two global production sites for the manufacture of its own-branded and white-label ranges of GMP-grade medicinal cannabis products, being a Danish production facility with a potential nameplate capacity of over 30 tonnes of cannabis biomas per annum and a West Australia premium indoor GMP production facility specialising in premium hand-crafted cannabis strains.

Little Green Pharma products comply with all required Danish Medicines Agency and Therapeutic Goods Administration regulations and testing requirements. With a growing range of products containing differing ratios of active ingredients, Little Green Pharma supplies medical-grade cannabis products to Australian, European and overseas markets.

The Company has a strong focus on patient access in the emerging global medicinal cannabis market and is actively engaged in promoting education and outreach programs, as well as participating in clinical investigations and research projects to develop innovative new delivery systems.

For more information about Little Green Pharma go to: www.littlegreenpharma.com

 


About us:

About Little Green Pharma Little Green Pharma is a global, vertically integrated and geographically diverse medicinal cannabis business with operations from cultivation and production through to manufacturing and distribution. The Company has two global production sites for the manufacture of its own-branded and white-label ranges of GMP-grade medicinal cannabis products, being a Danish production facility with a potential nameplate capacity of over 30 tonnes of cannabis biomas per annum and a West Australia premium indoor GMP production facility specialising in premium hand-crafted cannabis strains. Little Green Pharma products comply with all required Danish Medicines Agency and Therapeutic Goods Administration regulations and testing requirements. With a growing range of products containing differing ratios of active ingredients, Little Green Pharma supplies medical-grade cannabis products to Australian, European and overseas markets. The Company has a strong focus on patient access in the emerging global medicinal cannabis market and is actively engaged in promoting education and outreach programs, as well as participating in clinical investigations and research projects to develop innovative new delivery systems. For more information about Little Green Pharma go to: www.littlegreenpharma.comAbout Little Green PharmaLittle Green Pharma is a global, vertically integrated and geographically diverse medicinal cannabis business with operations from cultivation and production through to manufacturing and distribution.The Company has two global production sites for the manufacture of its own-branded and white-label ranges of GMP-grade medicinal cannabis products, being a Danish production facility with a potential nameplate capacity of over 30 tonnes of cannabis biomas per annum and a West Australia premium indoor GMP production facility specialising in premium hand-crafted cannabis strains.Little Green Pharma products comply with all required Danish Medicines Agency and Therapeutic Goods Administration regulations and testing requirements. With a growing range of products containing differing ratios of active ingredients, Little Green Pharma supplies medical-grade cannabis products to Australian, European and overseas markets.The Company has a strong focus on patient access in the emerging global medicinal cannabis market and is actively engaged in promoting education and outreach programs, as well as participating in clinical investigations and research projects to develop innovative new delivery systems.For more information about Little Green Pharma go to: www.littlegreenpharma.comAbout Little Green PharmaLittle Green Pharma is a global, vertically integrated and geographically diverse medicinal cannabis business with operations from cultivation and production through to manufacturing and distribution.The Company has two global production sites for the manufacture of its own-branded and white-label ranges of GMP-grade medicinal cannabis products, being a Danish production facility with a potential nameplate capacity of over 30 tonnes of cannabis biomas per annum and a West Australia premium indoor GMP production facility specialising in premium hand-crafted cannabis strains.Little Green Pharma products comply with all required Danish Medicines Agency and Therapeutic Goods Administration regulations and testing requirements. With a growing range of products containing differing ratios of active ingredients, Little Green Pharma supplies medical-grade cannabis products to Australian, European and overseas markets.The Company has a strong focus on patient access in the emerging global medicinal cannabis market and is actively engaged in promoting education and outreach programs, as well as participating in clinical investigations and research projects to develop innovative new delivery systems.For more information about Little Green Pharma go to: www.littlegreenpharma.com


Contact details:

David Tasker 

Chapter One Advisots

E: dtasker@chapteroneadvisors.com.au 

M: 0433 112 936

Media

More from this category

  • Medical Health Aged Care
  • 26/07/2024
  • 22:10
OmniGuide Holdings

OmniGuide Holdings Announces Successful Completion of Patient Study for Revolutionary iSTONE(TM) Laser-Guided Lithotripsy Technology

BILLERICA, MA / ACCESSWIRE / July 26, 2024 / OmniGuide Holdings, Inc. (OGH) is thrilled to announce the successful completion of a groundbreaking patient study for its innovative iSTONE™ software, a laser-guided system designed for real-time automatic target identification in endoscopic stone lithotripsy. This advancement marks a significant milestone in the treatment of urolithiasis, promising a new era of precision and safety in kidney stone management.In August 2022, the German Federal Ministry of Education and Research recognized the potential of this pioneering technology, awarding LISA Laser Products GmbH, a subsidiary of OmniGuide Holdings based in Germany, a prestigious grant (Grant…

  • Disability, Medical Health Aged Care
  • 26/07/2024
  • 12:57
Mr River Night

Fear as Services Australia Staff Face the Backlash from NDIS Communication Blackouts with its 600 000 + Participants

Available for Comment Radio – Live, Pre-recorded and Talkback, TV, Print Mr River Night Leading National Disability Sector Advocate Co-founder at Developing Australian Communities…

  • Contains:
  • Community, Medical Health Aged Care
  • 26/07/2024
  • 10:29
Eastern Health

Avoid the traps of winter

In the colder months older adults may find staying at home more often may cause feelings of isolation, affecting both mental and physical well-being. Often the most telling signs of a decline in one’s mental health are changes in patterns or behaviours, including; sleep, less motivation, more confusion and changes in appetite. The Eastern Health Older Adult Mental Health team see people over the age of 65, providing targeted treatment according to their individual needs. --------------------------------------------------------------------------------------------- PHOTOS: Available for downloadhere. --------------------------------------------------------------------------------------------- During the colder months it’s important to stay warm, however for older adults, staying at home more often may…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.